dataplor Launches Global Mobility Product, Expanding Foot Traffic Insights to Major Markets Worldwide
dataplor, a leading provider of global location intelligence, has announced the launch of its global mobility product, delivering high-quality, privacy-compliant foot traffic data across international markets. Designed to meet growing demand from multinational businesses, the product offers monthly refreshed insights into consumer movement patterns across cities, regions, and points of interest (POIs), especially in previously under-mapped markets. It’s one of the only global solutions built to deliver this depth of mobility data while maintaining General Data Protection Regulation (GDPR) compliance and end-user privacy.
To showcase the power of its new global dataset, dataplor is releasing the Global Foot Traffic Trends: What the World's Most Visited Places Reveal About Tourism’s Return report, which analyzes foot traffic at the world’s most visited tourist attractions. The report highlights how mobility data reveals meaningful insights about international travel patterns and regional consumer behavior from Tokyo Disneyland to the Great Pyramid at Giza.
“Global companies need the same level of location intelligence abroad that they’ve come to expect in the U.S.,” said Geoff Michener, CEO of dataplor. “With our international mobility product, businesses can now access comprehensive, GDPR-compliant foot traffic data across both developed and emerging markets, helping them make smarter decisions about where to invest, expand, and serve customers.”
New Applications Across Regions and Industries
With access to reliable mobility data across international markets, dataplor’s global offering empowers organizations to:
- Uncover new revenue opportunities by identifying untapped sales channels, benchmarking competitor foot traffic, and forecasting demand to inform international expansion and investment decisions.
- Enhance tourism and hospitality strategies by understanding how international visitors move through major cities, landmarks, and cultural destinations.
- Support smart city and infrastructure development through real-world mobility data that enables governments and urban planners to optimize transit systems, pedestrian flows, and city design.
As with its North American offering, dataplor ensures international mobility data is collected via anonymized signals mapped against its proprietary POI database. The result is a precision-focused, GDPR-compliant, ethically sourced dataset that respects user privacy while meeting the demands of modern global businesses.
For more information about the report and the global mobility product, read dataplor’s latest blog or visit www.dataplor.com.
About dataplor
dataplor is a leading provider of point-of-interest (POI) and mobility data that helps global enterprises grow abroad by mapping tough-to-reach markets with a privacy-first approach. As the majority of international location data is often inaccurate and quickly outdated, dataplor goes several steps beyond the industry standard, helping the world’s largest companies across technology, mapping, search, third-party logistics, consumer packaged goods (CPG), telecom, investing, real estate, and finance understand location intelligence about any commercial or physical location in real-time, fueling their expansion abroad.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250520519636/en/
Contacts
media@dataplor.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom